| 前收市價 | 52.50 |
| 開市 | 53.09 |
| 買盤 | 53.32 x 1000 |
| 賣出價 | 53.37 x 1100 |
| 今日波幅 | 52.45 - 53.84 |
| 52 週波幅 | 43.04 - 66.14 |
| 成交量 | |
| 平均成交量 | 513,924 |
| 市值 | 2.9B |
| Beta 值 (5 年，每月) | 2.07 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.90 |
| 業績公佈日 | 2024年8月01日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 74.10 |
Zacks5 Medical Info Systems Stocks to Buy for Stable Returns
We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.
ZacksHere's Why Enovis (ENOV) is Poised for a Turnaround After Losing -17.45% in 4 Weeks
Enovis (ENOV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksDown -15.45% in 4 Weeks, Here's Why You Should You Buy the Dip in Enovis (ENOV)
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
